Microsoft acquires Merck unit to expand life sciences

Microsoft announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co. Inc. The deal allows Microsoft to incorporate genetic, genomic, metabolomic and proteomics data management software into the Microsoft Amalga Life Sciences […]

Microsoft announced that it has signed an agreement with Merck & Co. Inc. to acquire certain assets of Rosetta Biosoftware, a business unit of Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co. Inc. The deal allows Microsoft to incorporate genetic, genomic, metabolomic and proteomics data management software into the Microsoft Amalga Life Sciences platform for enhanced translational research capabilities. In addition, Microsoft will establish a strategic relationship with Merck to enhance the Amalga Life Sciences platform to meet emerging pharmaceutical research needs.

More infoPressPass

About The Author

Deepak Gupta is a IT & Web Consultant. He is the founder and CEO of diTii.com & DIT Technologies, where he's engaged in providing Technology Consultancy, Design and Development of Desktop, Web and Mobile applications using various tools and softwares. Sign-up for the Email for daily updates. Google+ Profile.